Table of Contents

Some adverse effects come to light only after millions of people have taken a drug.

Improvement in surrogate end points may not necessarily translate into improvement in “hard” clinical end points.

The new drugs have a lower side effect profile, but caution is indicated when giving them to patients with a history of ACE inhibitor-induced angioedema.

Questions and answers on the visible signs of diseases.

These new “functional foods” reduce serum cholesterol and LDL levels modestly when used instead of regular margarine, butter, or oil. Are they worth it?

What is the cause of this patient’s symptoms? A self-test on a clinical case.

The FDA, after a recent study, asked manufacturers to pull dozens of products from the shelves.

The key to treating irritable bowel syndrome is to establish a therapeutic physician-patient relationship.

Improvements in MRI have increased its value in existing cardiovascular applications and opened the door to new uses.

One of the most complex issues facing breast cancer survivors and their physicians is how to manage menopause.

Heart failure can have an insidious onset, and the best time to intervene with ACE inhibitors and beta-blockers is early.

Shedding is not a disease, but it sometimes is a sign of a disease.